BD HorizonTM RY586 Mouse Anti-Human CD309 (VEGFR-2)

Description

Flow cytometric analysis of CD309 VEGFR-2 on HeLa and HUVEC cells. Cells from the Human HeLa Cervical adenocarcinoma, ATCC CCL-2; Left Plot cell line and HUVEC cells Right Plot were stained with either BD Horizon RY586 Mouse IgG1, kappa Isotype Control Cat. No. 568097; dashed line histograms or BD Horizon RY586 Mouse Anti-Human CD309 VEGFR-2 antibody Cat. No. 568812/568813; solid line histograms . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing CD309 VEGFR-2 expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Flow cytometric analysis of CD309 VEGFR-2 on HeLa and HUVEC cells. Cells from the Human HeLa Cervical adenocarcinoma, ATCC CCL-2; Left Plot cell line and HUVEC cells Right Plot were stained with either BD Horizon RY586 Mouse IgG1, kappa Isotype Control Cat. No. 568097; dashed line histograms or BD Horizon RY586 Mouse Anti-Human CD309 VEGFR-2 antibody Cat. No. 568812/568813; solid line histograms . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing CD309 VEGFR-2 expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Flow cytometric analysis of CD309 VEGFR-2 on HeLa and HUVEC cells. Cells from the Human HeLa Cervical adenocarcinoma, ATCC CCL-2; Left Plot cell line and HUVEC cells Right Plot were stained with either BD Horizon RY586 Mouse IgG1, kappa Isotype Control Cat. No. 568097; dashed line histograms or BD Horizon RY586 Mouse Anti-Human CD309 VEGFR-2 antibody Cat. No. 568812/568813; solid line histograms . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing CD309 VEGFR-2 expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Show More Flow cytometric analysis of CD309 VEGFR-2 on HeLa and HUVEC cells. Cells from the Human HeLa Cervical adenocarcinoma, ATCC CCL-2; Left Plot cell line and HUVEC cells Right Plot were stained with either BD Horizon RY586 Mouse IgG1, kappa Isotype Control Cat. No. 568097; dashed line histograms or BD Horizon RY586 Mouse Anti-Human CD309 VEGFR-2 antibody Cat. No. 568812/568813; solid line histograms . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing CD309 VEGFR-2 expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Show More Flow cytometric analysis of CD309 VEGFR-2 on HeLa and HUVEC cells. Cells from the Human HeLa Cervical adenocarcinoma, ATCC CCL-2; Left Plot cell line and HUVEC cells Right Plot were stained with either BD Horizon RY586 Mouse IgG1, kappa Isotype Control Cat. No. 568097; dashed line histograms or BD Horizon RY586 Mouse Anti-Human CD309 VEGFR-2 antibody Cat. No. 568812/568813; solid line histograms . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing CD309 VEGFR-2 expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Flow cytometric analysis of CD309 VEGFR-2 on HeLa and HUVEC cells. Cells from the Human HeLa Cervical adenocarcinoma, ATCC CCL-2; Left Plot cell line and HUVEC cells Right Plot were stained with either BD Horizon RY586 Mouse IgG1, kappa Isotype Control Cat. No. 568097; dashed line histograms or BD Horizon RY586 Mouse Anti-Human CD309 VEGFR-2 antibody Cat. No. 568812/568813; solid line histograms . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing CD309 VEGFR-2 expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software.